HomeINZY • NASDAQ
add
Inozyme Pharma Inc
Previous close
$3.43
Day range
$3.08 - $3.48
Year range
$3.08 - $7.79
Market cap
200.75M USD
Avg Volume
268.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.85M | 37.50% |
Net income | -24.57M | -47.67% |
Net profit margin | — | — |
Earnings per share | -0.39 | -34.48% |
EBITDA | -24.66M | -38.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.61M | -31.61% |
Total assets | 143.36M | -30.31% |
Total liabilities | 60.57M | 33.16% |
Total equity | 82.79M | — |
Shares outstanding | 64.24M | — |
Price to book | 2.66 | — |
Return on assets | -41.55% | — |
Return on capital | -45.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.57M | -47.67% |
Cash from operations | -24.53M | -30.00% |
Cash from investing | 23.35M | 152.33% |
Cash from financing | 10.52M | -84.91% |
Net change in cash | 9.34M | 54.41% |
Free cash flow | -15.80M | -5.88% |
About
Founded
2015
Headquarters
Website
Employees
59
